Patents by Inventor Yoshihiro Hayata

Yoshihiro Hayata has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8980257
    Abstract: It has been found out that among antibodies showing reactivity with wild type TGF-?, antibodies less reactive with G79A-substituted TGF-? have an excellent growth-suppressing effect on cancer cells having a mutated Ras gene. Further, it has been found out that most of these antibodies have an activity of inhibiting EGFR tyrosine phosphorylation and/or an induction-suppressing activity on vascular endothelial cells.
    Type: Grant
    Filed: May 17, 2011
    Date of Patent: March 17, 2015
    Assignee: Medical & Biological Laboratories Co., Ltd.
    Inventors: Makoto Kaneda, Yoshihiro Fujii, Yoshihiro Hayata, Yoshiro Kishi, Ichiro Yahara
  • Publication number: 20130131322
    Abstract: It has been found out that among antibodies showing reactivity with wild type TGF-?, antibodies less reactive with G79A-substituted TGF-? have an excellent growth-suppressing effect on cancer cells having a mutated Ras gene. Further, it has been found out that most of these antibodies have an activity of inhibiting EGFR tyrosine phosphorylation and/or an induction-suppressing activity on vascular endothelial cells.
    Type: Application
    Filed: May 17, 2011
    Publication date: May 23, 2013
    Applicant: MEDICAL & BIOLOGICAL LABORATORIES CO., LTD.
    Inventors: Makoto Kaneda, Yoshihiro Fujii, Yoshihiro Hayata, Yoshiro Kishi, Ichiro Yahara
  • Patent number: 4556057
    Abstract: Cancer diagnosis device contains an endoscope comprising a light pipe used to transmit light beams from respective light sources and an image guide used to observe the flesh of the organism during both diagnosis and treatment. The tip of the endoscope faces toward the focuses where a photosensitive material having an affinity to the focuses of cancer has been absorbed so that a treatment for cancer can be performed by exposing the organism affected by cancer to the laser beam. The attainable the laser beam within a focus is thus increased by the use of the laser beam pulse from a first laser beam pulse source.
    Type: Grant
    Filed: March 11, 1983
    Date of Patent: December 3, 1985
    Assignee: Hamamatsu TV Co., Ltd.
    Inventors: Teruo Hiruma, Atsushi Honma, Tooru Hirano, Yutaka Tsuchiya, Yoshihiro Hayata, Katsuo Aizawa, Harubumi Kato, Keiji Kainuma